dRASTTM, direct & Rapid Antimicrobial Susceptibility Test
dRAST provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture in as low as 4 hours; reducing time to results by up to 2 days compared to conventional method. The rapid results allow for earlier optimization of antibiotics in critically-ill patients with bloodstream infections and sepsis.
- Dedicated to positive blood culture samples
- Provides phenotypic MIC in as low as 4 hours
- Random access with up to 12 samples simultaneously (15 panel positions)
- Expert system on board with choice of guidelines
- Easy start with no McFarland required, no sample prep
- 2 panels: 1 Gram Neg. + 1 Gram Pos.
- Easy to use, fast to operate
- No daily maintenance
QuantaMatrix's microbial diagnostics solutions are the first to be developed in Korea and have received the highest honors including the New Excellent Technology (NET) certification and new medical technology certification.
2 days faster than conventional AST
Conventional AST from blood can take at least three days or longer to produce results, as bacteria first has to be detected in blood and a pure isolate obtained before AST can proceed. dRAST, on the other hand, utilizes microfluidic technology and microscopic imaging technology that eliminates the need for pure isolate, to enable much faster results that can impact optimize antibiotic prescribing sooner.
Our dRAST test kit consists of Panel, Agarose, and Broth.
96-well plate with panel of dried-down antibiotics at various concentrations
Gel used for bacterial immobilization
Pipette tips and broth dispensed to enable bacterial growth
Gram-positive and Gram-negative panels using either CLSI or EUCAST recommended antimicrobials and breakpoints are available for dRAST.
- Touchscreen user interface (UI)
- Intuitive result reporting
- Bi-directional LIS connectivity
- Compatible with all major LIS
- Random access and fully automated to improve workflow
- Custom expert rules to accommodate individual lab guidelines
- Integration with international and local guidelines (EUCAST, CLSI, and CA-SFM)
- Real-time display of raw data and interpreted results
- Display of MICs and SIR determination in a single screen
- Activated comments and rules for each sample, allowing the clinicians and infectious disease specialists to get all the relevant information